Skip to main content

Narwhal Capital Management

Position in NVS — Novartis AG

CIK 1461287 MARIETTA, GA

Position in NVS

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$8,259,457
+$214,420 QoQ
Shares Held
52,702
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#192
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Narwhal Capital Management holds $69,832,145 across 5 Drug Manufacturers - General names. NVS ranks #4 (11.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVS
Novartis AG
This page
52,702 $8,259,457

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,259,457 52,702
2026-03-31 $8,045,037 52,668
2025-12-31 $7,419,060 53,812
2025-09-30 $6,658,862 51,925
2025-06-30 $6,142,467 50,760
2025-03-31 $5,794,953 51,982
2024-12-31 $5,177,670 53,208
2024-09-30 $6,196,702 53,875
2024-06-30 $5,745,326 53,967
2024-03-31 $5,173,797 53,487
2023-12-31 $5,410,275 53,583
2023-09-30 $5,508,181 54,076
2023-06-30 $5,539,454 54,895
2023-03-31 $5,075,916 55,173
2022-12-31 $5,014,910 55,279
2022-09-30 $4,208,597 55,369
2022-06-30 $4,680,341 55,369
2022-03-31 $4,774,740 54,413
2021-12-31 $5,000,659 57,170
2021-09-30 $5,719,529 69,938
2021-06-30 $7,855,490 86,097
2021-03-31 $8,617,153 100,809
2020-12-31 $9,922,893 105,082
2020-09-30 $8,316,245 95,633
2020-06-30 $7,786,972 89,157
2020-03-31 $6,856,542 83,160